Dene Peters
944 posts
@DrugsJournal
The Editor of Drugs, the definitive journal of drugs and therapeutics, providing independent and crucial information by leading clinicians and researchers.
My first, first author paper is now published in @DrugsJournal🎉This review discusses current GIST TKI treatments and how our understanding of the molecular mechanisms of the GIST subtypes can inform the development of more successful targeted therapies. link.springer.com/article/10.100…
Great review on gabapentinoids (gabapentin or pregabalin) for pain just published in @DrugsJournal with authors suggesting prescribers should be cautious, particularly with using these agents for a prolonged period #pain link.springer.com/article/10.100…
🔥Brandnew review on new antifungals in clinical trials! @DrugsJournal Looking forward to see them in clinical use! Sincere thanks @martinhoenigl @CornelyOliver @Amir36520680 @JeffreyJenks5 @jprattes @GRThompsonMD Fantastic figures from @matteosciart 🔗bit.ly/3DpGTX9
